The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort
about
Molecular Genetic of Atopic dermatitis: An UpdateAdvances in understanding and managing atopic dermatitisHypothetical Atopic Dermatitis-Myeloproliferative Neoplasm SyndromeDeciphering the complexities of atopic dermatitis: shifting paradigms in treatment approachesNew era of biologic therapeutics in atopic dermatitisThe Pathogenetic Effect of Natural and Bacterial Toxins on Atopic DermatitisGenetic and epigenetic studies of atopic dermatitisDefects of corneocyte structural proteins and epidermal barrier in atopic dermatitisThe Long-Term Course of Atopic Dermatitis.Loss of Mpzl3 function causes various skin abnormalities and greatly reduced adipose depotsRacial comparison of filaggrin null mutations in asthmatic patients with atopic dermatitis in a US population.Exome sequencing of filaggrin and related genes in African-American children with atopic dermatitis.Staphylococcal and streptococcal superantigen exotoxinsThe Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma.Persistence of mild to moderate atopic dermatitis.Thymic stromal lymphopoietin variation, filaggrin loss of function, and the persistence of atopic dermatitisAsthma and frequency of wheeze: risk factors for the persistence of atopic dermatitis in children.Association Between Malignancy and Topical Use of Pimecrolimus.Association of HLA-DRB1 genetic variants with the persistence of atopic dermatitis.In a three-dimensional reconstructed human epidermis filaggrin-2 is essential for proper cornification.Interleukin-4 Downregulation of Involucrin Expression in Human Epidermal Keratinocytes Involves Stat6 Sequestration of the Coactivator CREB-Binding Protein.Reliability and validity of genotyping filaggrin null mutations.Warm, humid, and high sun exposure climates are associated with poorly controlled eczema: PEER (Pediatric Eczema Elective Registry) cohort, 2004-2012.Filaggrin-2 variation is associated with more persistent atopic dermatitis in African American subjects.Optimizing outcomes for paediatric atopic dermatitis.The Genetics and Epigenetics of Atopic Dermatitis-Filaggrin and Other Polymorphisms.Variations in risk of asthma and seasonal allergies between early- and late-onset pediatric atopic dermatitis: A cohort study.Drug evaluation review: dupilumab in atopic dermatitis.SPINK5 is associated with early-onset and CHI3L1 with late-onset atopic dermatitis.The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.Prevalence of comorbidity and associated risk factors in adults with atopic dermatitis.Influence of FLG mutations and TSLP polymorphisms on atopic dermatitis onset age.Filaggrin-2 barrier protein inversely varies with skin inflammation.South African amaXhosa patients with atopic dermatitis have decreased levels of filaggrin breakdown products but no loss-of-function mutations in filaggrin.Do children really outgrow their eczema, or is there more than one eczema?Atopic Dermatitis: Disease Background and Risk Factors.Atopic Eczema: Genetic Associations and Potential Links to Developmental Exposures.Peeling skin syndrome associated with novel variant in FLG2 gene.Filaggrin gene mutations in African Americans with both ichthyosis vulgaris and atopic dermatitis.
P2860
Q26752702-3234AB88-7042-44E6-9ECB-33F86CEF96C5Q26766224-71F407BB-CD20-447A-A5A7-5FA20DA2A09BQ26784465-7CB0E4E3-01CA-4ACD-9CDA-7FA144FBEDB0Q26852335-9E606CB0-6734-4C5F-9318-E27D0FB140E7Q27001941-7BC0C3CE-233A-44FA-BEB2-B3B5559100FEQ28068840-BCE93BCA-E33E-4035-9267-55849B1428B1Q28073454-2CABBC88-0324-4449-9646-2C84E6136A40Q28085608-13A2846D-9580-492F-A00C-AD688FF6BC55Q30234105-4543A995-10B4-4990-AB67-D664E2D5F846Q33756669-7FA3B5FD-2EB0-49DB-965C-96E740A2BFDBQ33874318-97051B3C-4B0C-4C85-80D1-86FB2E7C455BQ33916764-4F15B8FA-FAD0-40E7-91B7-B69CB5CF50D8Q34355243-1719F627-0460-4ED3-A6BC-0C55DC0998EBQ34556081-D3A37835-DB70-4136-B356-DFE49EBC6A6DQ35155669-1B3749C1-0788-4E23-910F-DE0E85ECD62DQ35553105-4CF24E36-3CAF-43B7-8AA3-42E46A83D8C4Q35670538-753D5112-E8ED-4A8F-A312-4D21776F93BAQ35733343-D5209AFE-540B-405C-8311-CE66868DD0D0Q36122531-DD9768B0-5B0D-49C9-A272-05788F7CECFDQ36347302-CC6E3E0C-5A60-4725-8226-563C9C7935BCQ36966552-DC47D8D0-7CB4-4AEA-878B-6C6F9164159AQ37009417-2C6F86E6-C007-49F7-A39C-F09F1237670BQ37407574-6D97868B-EF44-41EE-8493-61BEC28C7E27Q37619379-C29F3323-F145-422B-B2B1-BA3213AC9235Q38203613-E9F89201-5CA7-4F8E-B358-6630E55AB8B7Q38589257-0BC5A1F5-C4E6-4339-BFC4-023741FDDD02Q38619479-8A3D12D9-0BEE-4068-A459-20CC78D326F3Q38645192-0E6D8264-C187-489A-822C-4E175FF5C013Q38662187-2994E56C-2CEE-4E37-AC4F-955A448F2E46Q38733182-F8E27D63-7A66-4085-AA8C-8752C0217B2EQ39172604-4CA293D2-A562-4177-B994-5E774D048A71Q40212108-25ADBAE5-4608-4FC8-BBBE-A7AB609FBC19Q41755207-B590BC09-FEED-47AB-B4D9-B1A0127C0E6DQ42753619-B5FFC0CB-AE93-4EA7-9BE3-D0B44A0BABCDQ43036136-5B1B59C5-627F-4327-8E0E-D3404BD0E8DEQ47602738-E14C3421-3AE8-4D6E-9628-3A1752802E51Q50448143-A9772878-4406-4360-93DC-A0D5C3C62B00Q53081175-200E3B97-4B0A-43D5-B23E-32EBE6ADBC71Q54203713-86AD3338-B5BF-453B-951A-3D15E47DD2F2
P2860
The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The persistence of atopic derm ...... ns in a US longitudinal cohort
@ast
The persistence of atopic derm ...... ns in a US longitudinal cohort
@en
type
label
The persistence of atopic derm ...... ns in a US longitudinal cohort
@ast
The persistence of atopic derm ...... ns in a US longitudinal cohort
@en
prefLabel
The persistence of atopic derm ...... ns in a US longitudinal cohort
@ast
The persistence of atopic derm ...... ns in a US longitudinal cohort
@en
P2093
P2860
P1476
The persistence of atopic derm ...... ns in a US longitudinal cohort
@en
P2093
Aileen Sandilands
Andrea J Apter
David J Margolis
Jayanta Gupta
Linda E Campbell
Maryte Papadopoulos
Nandita Mitra
Ole Hoffstad
Tim R Rebbeck
W H Irwin McLean
P2860
P304
P356
10.1016/J.JACI.2012.07.008
P407
P577
2012-08-27T00:00:00Z